Respironics Income Statement
View: Annual | Quarterly
| Jun 07 | Jun 06 | Jun 05 | |
|---|---|---|---|
| Revenue | 1,195.0 | 1,046.1 | 911.5 |
| Cost of Goods Sold | 555.8 | 473.3 | 413.2 |
| Gross Profit | 639.2 | 572.9 | 498.3 |
| Gross Profit Margin | 53.5% | 54.8% | 54.7% |
| SG&A Expense | 410.6 | 365.5 | 318.1 |
| Depreciation & Amortization | 65.1 | 57.8 | 46.3 |
| Operating Income | 163.5 | 149.6 | 133.9 |
| Operating Margin | 13.7% | 14.3% | 14.7% |
| Nonoperating Income | 11.3 | 9.6 | 1.8 |
| Nonoperating Expenses | -- | -- | -- |
| Income Before Taxes | 174.8 | 159.2 | 135.7 |
| Income Taxes | 52.5 | 59.3 | 51.4 |
| Net Income After Taxes | 122.3 | 99.9 | 84.4 |
| Continuing Operations | 122.3 | 99.9 | 84.4 |
| Discontinued Operations | -- | -- | -- |
| Total Operations | 122.3 | 99.9 | 84.4 |
| Total Net Income | 122.3 | 99.9 | 84.4 |
| Net Profit Margin | 10.2% | 9.5% | 9.3% |
| Diluted EPS from Total Net Income ($) | 1.66 | 1.36 | 1.17 |
| Dividends per Share | -- | -- | -- |





